Giampaolo Merlini
Università degli Studi di Pavia
H-index: 124
Europe-Italy
Top articles of Giampaolo Merlini
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Development and Validation of Staging Systems for AA Amyloidosis | Journal of the American Society of Nephrology | Marco Basset Stefan O Schönland Laura Obici Janine Günther Eloisa Riva | 2024/2/6 |
Healthcare resource utilization and cost-of-illness in systemic light chain (AL) amyloidosis in Europe: results from the real-world, retrospective EMN23 study | Clinical Lymphoma Myeloma and Leukemia | Arnaud Jaccard Frank Bridoux Wilfried Roeloffzen Monique C Minnema Rui Bergantim | 2024/2/1 |
International Myeloma Working Group immunotherapy committee consensus guidelines and recommendations for optimal use of T-cell-engaging bispecific antibodies in multiple myeloma | The Lancet Oncology | Paula Rodriguez-Otero Saad Usmani Adam D Cohen Niels WCJ van de Donk Xavier Leleu | 2024/5/1 |
Cardiac Amyloidosis: Open Issues and Future Perspectives | Michele Emdin Giuseppe Vergaro Alberto Aimo Marianna Fontana Giampaolo Merlini | 2024/3/28 | |
Mining the amyloid-plaque proteome to uncover disease mechanisms in renal amyloidoses | Kidney International | Mario Nuvolone Giampaolo Merlini | 2024/3/1 |
Daratumumab-Based Regimens Versus Cybord in Newly Diagnosed Patients with AL Amyloidosis and IIIb Cardiac Stage: A Matched Case-Control Study | Blood | Claudia Bellofiore Marco Basset Pietro Benvenuti Mario Nuvolone Andrea Foli | 2023/11/28 |
Graded cardiac response criteria for patients with systemic light chain amyloidosis | Journal of Clinical Oncology | Eli Muchtar Angela Dispenzieri Brendan Wisniowski Giovanni Palladini Paolo Milani | 2023/3/1 |
P56 SURVIVAL BENEFIT OF BIRTAMIMAB IN MAYO STAGE IV AL AMYLOIDOSIS IN THE PHASE 3 VITAL STUDY WAS CONSISTENT ACROSS ALL KEY BASELINE VARIABLES | HemaSphere | M Gertz A Cohen R Comenzo E Kastritis H Landau | 2023/5/1 |
Iter diagnostico dei pazienti con sospetta amiloidosi cardiaca: il ruolo guida del laboratorio diagnostico. | Biochimica Clinica | Alice Nevone Giulia Mazzini Serena Caminito Maria Girelli Monica Russo | 2023/6/1 |
The Cryo-EM structure of renal amyloid fibril suggests structurally homogeneous multiorgan aggregation in AL amyloidosis | Journal of Molecular Biology | Sarita Puri Tim Schulte Antonio Chaves-Sanjuan Giulia Mazzini Serena Caminito | 2023/9/15 |
Echocardiographic findings in subjects with an amyloidogenic apolipoprotein A1 pathogenic variant | Amyloid | Daniela Tomasoni Alberto Aimo Marianna Adamo Matilde Nardi Carlo Mario Lombardi | 2023/7/3 |
The management of light chain (AL) amyloidosis in Europe: clinical characteristics, treatment patterns, and efficacy outcomes between 2004 and 2018 | Blood cancer journal | Giovanni Palladini Stefan Schönland Giampaolo Merlini Paolo Milani Arnaud Jaccard | 2023/1/25 |
Efficacy and Safety of Daratumumab Monotherapy in Newly Diagnosed Patients with Stage 3B Light-Chain Amyloidosis: A Phase 2 Study By the European Myeloma Network | Blood | Efstathios Kastritis Monique C Minnema Meletios A Dimopoulos Giampaolo Merlini Foteini Theodorakakou | 2023/11/28 |
Quality of life and symptoms among patients with relapsed/refractory AL amyloidosis treated with ixazomib‐dexamethasone versus physician's choice | American journal of hematology | Vaishali Sanchorawala Ashutosh D Wechalekar Kihyun Kim Stefan O Schönland Heather J Landau | 2023/5 |
Impact of cytogenetic abnormalities on treatment outcomes in patients with amyloid light-chain amyloidosis: subanalyses from the ANDROMEDA study | Amyloid | Shaji Kumar Angela Dispenzieri Divaya Bhutani Morie Gertz Ashutosh Wechalekar | 2023/7/3 |
‘Standing on the Shoulders of the Giants’: Dr. Giampaolo Merlini | Mohamad Mohty Giampaolo Merlini | 2023/6 | |
Proteinuria e albuminuria nelle discrasie plasmacellulari | Biochimica Clinica | Marco Basset Paolo Milani Tiziana Bosoni Mario Nuvolone Riccardo Albertini | 2023/9/2 |
Guidelines for non-transplant chemotherapy for treatment of systemic AL amyloidosis: EHA-ISA working group | Ashutosh D Wechalekar M Teresa Cibeira Simon D Gibbs Arnaud Jaccard Shaji Kumar | 2023/1/2 | |
Hepatic Response and Progression Criteria in Light Chain Amyloidosis: A Multicenter Validation Study | Blood | Eli Muchtar Giovanni Palladini Stefan Schonland Angela Dispenzieri Brendan Wisniowski | 2023/11/28 |
Nanobodies counteract the toxicity of an amyloidogenic light chain by stabilizing a partially open dimeric conformation | Journal of Molecular Biology | Luca Broggini Maria Monica Barzago Valentina Speranzini Tim Schulte Federica Sonzini | 2023/12/15 |
